841
Views
22
CrossRef citations to date
0
Altmetric
Invited Article

Liquid crystal blue phases: stability, field effects and alignment

, , , &
Pages 760-771 | Received 02 Oct 2014, Published online: 31 Mar 2015
 

Abstract

The blue phases are fascinating structures in liquid crystals, fluids that exhibit cubic structures that have true crystalline order. The blue phases were discovered in the 1970s and were the subject of extensive research in the 1980s, when a deep understanding of many of their properties was established. The discovery that the blue phases could be stabilised to exist over wide temperature ranges meant that they became more than scientific curiosities and led to a recent resurgence in research into them as they offer some promise in applications. This paper considers some important aspects of the blue phases that are recurrent topics in their research. It describes factors affecting blue phase stability, demonstrating on the role of the bend elastic constant; field effects, including the Kerr effect, electrostriction and relaxation phenomena; and alignment, in particular production and control of blue phase monodomains. The dependence of these phenomena on the physical properties of the liquid crystalline system, including the twist and bend elastic constants and the dielectric anisotropy, is emphasised wherever possible. The paper links work carried out in the 1980s with contemporary research, using a few key examples to show how there is still much to understand in this beautiful topic.

Notes

1. There are some beautiful examples of blue phase textures on the International Liquid Crystal website including June 2014, June August and October 2010 and January 2009. The site can be found at http://www.lcinet.kent.edu/ILCS/main/page137/page137.html.

2. The TM74 and TM75 base mixtures were provided by British Drugs Houses (BDH).

Additional information

Funding

The work included in this paper was carried out with financial support from the EPSRC [including grant numbers EP/G023093 and EP/D055261/1], Merck Ltd (Chilworth), the Royal Society and the University of Manchester. The authors are grateful for this support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.